Andreas Michael Zeiher

Title: **Andreas Michael Zeiher: A Pioneer in Angiogenesis Research**

Introduction

Andreas Michael Zeiher, an esteemed inventor based in Frankfurt-am-Main, Germany, has made significant contributions to the field of biomedical research. With a total of 11 patents to his name, his innovative approaches have opened new pathways in understanding and manipulating angiogenesis.

Latest Patents

Among his latest inventions are methods for influencing miR-92 expression in cells. The inventions include techniques for either reducing miR-92 expression to promote vascularization and vessel repair or increasing miR-92 expression to inhibit tumor angiogenesis. These methods involve the introduction of antisense molecules against miR-92 and constructs for expressing miR-92, providing valuable pharmaceutical compositions for potential therapeutic applications.

Career Highlights

Throughout his career, Andreas has collaborated with leading companies such as T2cure GmbH and Siemens Healthcare Diagnostics Products GmbH. His work has positioned him as a leading figure in the industry, particularly in the exploration of genetic and molecular methods to control angiogenesis.

Collaborations

Andreas has worked alongside notable coworkers, including Stefanie Dimmeler and Christopher Heeschen. Their collaborative efforts have advanced the collective understanding of vascular biology, leading to breakthroughs in cancer research and regenerative medicine.

Conclusion

In conclusion, Andreas Michael Zeiher's innovative contributions to angiogenesis research underscore his role as a pioneering inventor. His patents not only reflect his expertise but also the potential for significant advancements in therapeutic interventions pertaining to vascular health and cancer treatment.